congress on Obsterics, Gynecology: Home
congress on Obsterics, Gynecology: Committees
congress on Obsterics, Gynecology: Timetable
congress on Obsterics, Gynecology: Final Program
Proceedings
   
Click here for
Poster sessions


FRIDAY, APRIL 25, 2003


SATURDAY, APRIL 26, 2003


SUNDAY, APRIL 27, 2003

 

SUNDAY, APRIL 27, 2003
   
Infertility and ART Hall A
08:30 - 10:00 ANTAGONISTS FOR ART
Co-Chair: R. Felberbaum, Germany
C.J. Thaler, Germany
M. Szamatowicz, Poland
Capsule: Without the flare–up effect, short and long acting antagonists are emerging as potent adjunct to fertility treatment
  1. Antagonists or Agonist - What to prefer?
    J. Cohen, France
  2. Single or multiple doses? Individually adjusted?
    K. Diedrich, Germany
  3. The use of Antagonist for low responders?
    A. Hazout, France
  4. Antagonists for ART without twins
    P.G. Crosignani, Italy
10:30 - 12:30 PREGNANCY LOSS
Co-Chair: N. Gleicher, USA
M. Hansmann, Germany
A.G. Schmutzler, Germany
Capsule: Confusion exists over the treatment of this common condition
  1. Consequences of first trimester endocrinology for diagnosis and treatment of pregnancy failure
    A.E. Schindler, Germany
  2. Early pregnancy loss, is there any treatment? Can progesterone help?
    L. Kiesel, Germany
  3. Maternal autoimmune disease can it affect future generations?
    N. Gleicher, USA
  4. The end of immunotherapy?
    S. Daya, Canada
  5. Can PGD overcome recurrent pregnancy failure?
    Y. Verlinsky, USA
13:15-15:15 EMBRYO TRANSFER
Co-Chair: R. Aurell, Spain
L. Kiesel, Germany
D. Levran, Israel
Capsule: The most crucial step of IVF is replacement and implantation. Are we doing something wrong?
  1. PGD- Polar body or blastomere is this the question?
    Y. Verlinsky, USA
  2. ET: Can the technique affect the results?
    H. Sallam, Egypt
  3. How many embryos to replace? Increase in pregnancy rate or limit multiple pregnancy by law
    P. Barri, Spain
  4. Assisted hatching - is it time to call it off?
    S. Daya, Canada
  5. The assessment of early embryonic stages and the decision for transfer to achieve implantation
    H. Beier, Germany
Gynecology/Menopause and Family Planning Hall B
08:30 – 10:00 AGING MALE
Co-Chair: B. Lunenfeld, Israel
T. Rabe, Germany
F. Comhaire, Belgium
Capsule: Should we view the gradual fall in hormones with aging a true hormone deficiency state?
Is hormonal treatment effective?
  1. Andropause - fact or fiction?
    B. Lunenfeld, Israel
  2. Anti-aging strategies using vitamins and "natural" products
    F. Comhaire, Belgium
  3. DHEAS for longevity and quality of life?
    A. Genazzani, Italy
  4. GH or Testosterone. Does anything help?
    J. Studd, UK
10:30 – 12:30 HYSTERECTOMY AND MYOMECTOMY
Co-Chair: A. Wattiez, France
Capsule: Disagreement exist over basic aspects of these common procedures
  1. Can emobolization be used for fertility preservation?
    R. Shaw, UK
  2. Laparoscopic hysterectomy - why it is not more popular?
    J. Donnez, Belgium
  3. Most uteri can be taken out through the vagina
    L. Mettler, Germany
  4. Myomectomy during c-section. Time to reconsider?
    Z. Ben Rafael, Israel
13:15-15:15 UROGYNECOLOGY
Co-Chair S. Stanton, UK
Capsule: Innovative solutions offer further treatment to this gender specific problem
  1. Is Urodynamic test obsolete?
    S. Stanton, UK
  2. Laparoscopy Burch. Fancy operation or real need?
    A. Wattiez, France
  3. Is there a place for any treatment other than TVT?
    S. Stanton, UK
  4. Interstitial cystitis - what is it and why it should interest the gynecologist?
    C. Doehn, Germany
  5. Role of Estrogens in older patients with recurrent UTI
    S. Rozenberg, Belgium
Perinatology and Prenatal Diagnosis Hall C
08:30-10:00 CONTROVERSIES IN NEONATOLOGY I
Co-Chair: M. Levene, UK
K. Bauer
, Germnay
E.S. Shinwell, Israel
Capsule: State of the Art Care for the Fetus and Newborn 2003- Where is the evidence?
  1. Perinatal and neonatal dilemmas at the limits of viability
    A. Eidelman, Israel
  2. Pre- and postnatal inflammatory events in chronic lung disease of preterm infants
    C. Speer, Germany
  3. Do developmental therapies influence the outcome of very premature infants?
    A. Eidelman, Israel
  4. Postnatal Steroid therapy and other adverse influences on the neonatal brain
    E.S. Shinwell, Israel
  5. Synthetic humanized surfactant-a promise for the future?
    J. Gadzinowski, Poland
10:30 – 12:30 THE BREECH DEBATE AND OTHER HOT CONTROVERSIES
Co-Chair: J. Gardosi, UK
K. Vetter
, Germany
Z. Hagay, Israel
Capsule: Recent studies claim that vaginal delivery of breech is unsafe
  1. Debate: All breeches at term should be delivered by elective Caesarean Section -
    Pros: M. Hannah, Canada
    Cons: C. O'Herlihy, Ireland
  2. Evidence-based Perinatal Medicine: What is the evidence?
    M. Mongelli, Singapore
  3. Can shoulder dystocia be prevented? what is the price?
    I. Blickstein, Israel
  4. Clinical significant of an antenatal nuchal cord
    J.F. Clapp, USA
13:15-15:15 CONTROVERSIES IN NEONATOLOGY II
Co-Chair: C.P. Speer, Germany
A.I. Eidelman, Israel
M. Szymankiewicz, Poland
Capsule: State of the Art Care for the Fetus and Newborn 2003- Where is the evidence?
  1. Are neuroprotective therapies a reality?
    M. Levene, UK
  2. Prevention of perinatal infection - GBS and others
    A.A. Fanaroff, USA - to be confirmed
  3. Multiple pregnancy and cerebral palsy - the effect of prematurity or more?
    I. Blickstein, Israel
  4. The role of oxygen in the resuscitation of the newborn
    O.D. Saugstad, Norway



FRIDAY, APRIL 25, 2003


SATURDAY, APRIL 26, 2003


SUNDAY, APRIL 27, 2003

 

     

Home | Committees | Final Program |
Proceedings
COGI World Congresses